| |
 |
|
Class Information
Number: 514/56
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > Polysaccharide > Heparin or derivative
Description: Subject matter wherein the polysaccharide has the following repeating unit, illustrated below, wherein the degree of sulfation of the individual components in the polysaccharide chain, and derivatives thereof.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7598224 |
Dual chain synthetic heparin-binding growth factor analogs |
Oct. 6, 2009 |
| 7585642 |
Methods for evaluating the quality of a heparin sample |
Sep. 8, 2009 |
| 7575886 |
Analysis of sulfated polysaccharides |
Aug. 18, 2009 |
| 7563762 |
Composition and process for stabilizing of biomolecules |
Jul. 21, 2009 |
| 7563780 |
Heparin prodrugs and drug delivery stents formed therefrom |
Jul. 21, 2009 |
| 7560444 |
Polysaccharides for pulmonary delivery of active agents |
Jul. 14, 2009 |
| 7553872 |
Compounds and compositions for delivering active agents |
Jun. 30, 2009 |
| 7550443 |
Process and systems for biocompatible surfaces |
Jun. 23, 2009 |
| 7550444 |
Composition and method for preparing biocompatible surfaces |
Jun. 23, 2009 |
| 7538096 |
Treatment and prevention of abnormal cellular proliferation |
May. 26, 2009 |
| 7504113 |
Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
Mar. 17, 2009 |
| 7479505 |
Use of taurolidine to treat tumors |
Jan. 20, 2009 |
| 7468210 |
Cross-linked heparin coatings and methods |
Dec. 23, 2008 |
| 7468358 |
Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome |
Dec. 23, 2008 |
| 7449200 |
Nanoparticles for protein/peptide delivery and delivery means |
Nov. 11, 2008 |
| 7407945 |
Use of sulfated glycosaminoglycans for establishing effective labor in women |
Aug. 5, 2008 |
| 7399604 |
Methods and products related to evaluating the quality of a polysaccharide |
Jul. 15, 2008 |
| 7393840 |
Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
Jul. 1, 2008 |
| 7332480 |
Compositions for the regulation of cytokine activity |
Feb. 19, 2008 |
| 7297343 |
Bioactive medical films |
Nov. 20, 2007 |
| 7279183 |
Method of reducing thrombosis and complications after arterial angioplasty using stent coated with magnesium-based compound |
Oct. 9, 2007 |
| 7276491 |
Anticoagulant and fibrinolytic therapy using p38 MAP kinase inhibitors |
Oct. 2, 2007 |
| 7235536 |
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
Jun. 26, 2007 |
| 7226914 |
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
Jun. 5, 2007 |
| 7214667 |
Drugs against articular failure |
May. 8, 2007 |
| 7202230 |
Use of hyaluronic acid derivatives in the preparation of biomaterials with a physical haemostatic and plugging activity |
Apr. 10, 2007 |
| 7202087 |
Anticoagulant composition |
Apr. 10, 2007 |
| 7196073 |
Imine-forming polysaccharide adjuvants and immunostimulants |
Mar. 27, 2007 |
| 7192984 |
Compositions of polyacids and polyethers and methods for their use as dermal fillers |
Mar. 20, 2007 |
| 7157445 |
Administration of enoxaparin sodium to patients with severe renal impairment |
Jan. 2, 2007 |
| 7151099 |
Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases |
Dec. 19, 2006 |
| 7132413 |
Anticoagulant/sterilizing compositions and methods |
Nov. 7, 2006 |
| 7129224 |
Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
Oct. 31, 2006 |
| 7101859 |
Use of lipid conjugates in the treatment of diseases |
Sep. 5, 2006 |
| 7078392 |
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
Jul. 18, 2006 |
| RE39192 |
Supplemented and unsupplemented tissue sealants, methods of their production and use |
Jul. 18, 2006 |
| 7071174 |
Method and composition for inhibiting cholesterol esterase |
Jul. 4, 2006 |
| 7067119 |
Compounds and compositions for delivering active agents |
Jun. 27, 2006 |
| 7034061 |
Non-thrombogenic and anti-thrombogenic polymers |
Apr. 25, 2006 |
| 7034006 |
Use of lipid conjugates in the treatment of disease |
Apr. 25, 2006 |
| 7014655 |
Method for conserving biological prostheses, conserved biological prostheses and conserving solutions |
Mar. 21, 2006 |
| 7011953 |
Diagnostic assay for type 2 heparin-induced thrombocytopenia |
Mar. 14, 2006 |
| 7008933 |
Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights |
Mar. 7, 2006 |
| 7005426 |
Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active component |
Feb. 28, 2006 |
| 6979680 |
Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia |
Dec. 27, 2005 |
| 6977248 |
Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry |
Dec. 20, 2005 |
| 6969705 |
Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
Nov. 29, 2005 |
| 6960452 |
Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins |
Nov. 1, 2005 |
| 6953784 |
Cross-linked polysaccharide drug carrier |
Oct. 11, 2005 |
| 6943154 |
Water insoluble derivatives of polyanionic polysaccharides |
Sep. 13, 2005 |
|
|
|
